Showing results (201-210 of 217) with videos related to
Sort By:
Pageof 22
Journal of Pediatric Surgery|September 24, 2024
Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531Erin G Brown, E Stanton Adkins, Peter Mattei, et al.JCO Precision Oncology|December 29, 2021
Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid TumorJaclyn Schienda, Alanna J Church, Laura B Corson, et al.The New England Journal of Medicine|October 1, 2010
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastomaAlice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.Oncotarget|February 22, 2018
MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology groupRisa Niemas-Teshiba, Ryosuke Matsuno, Larry L Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2022
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology GroupAmi V Desai, Andrew L Gilman, Mehmet Fevzi Ozkaynak, et al.JCO Clinical Cancer Informatics|August 24, 2021
Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult CancerAnthony R Kerlavage, Anne C Kirchhoff, Jaime M Guidry Auvil, et al.Journal of the National Cancer Institute|July 30, 2011
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug effluxMichelle J Henderson, Michelle Haber, Antonio Porro, et al.Pediatric Blood & Cancer|June 30, 2012
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology CommitteeRie Suganuma, Larry L Wang, Hideki Sano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2022
Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor StudyDanielle Novetsky Friedman, Pamela J Goodman, Wendy M Leisenring, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology GroupFlorette K Hazard, Angus M S Toland, Serena Y Tan, et al.Pageof 22